Ten patients diagnosed with lower extremity CRPS were included in the study. Researchers performed four IV regional blocks, one week apart, with 50 mL 0.5 percent lidocaine in conjunction with 0, 30, 60 and 120 mg ketorolac. Researchers then assessed pain with the numeric rating scale one week postinjection. Other outcomes measured included pain with motion, joint pain score, edema and short-term pain relief.
Results showed improvement only in pain reduction for one day in the ketorolac groups. Additionally, edema was not significantly reduced.
Read the study about IV regional blocks with ketorolac and lidocaine for patients with CRPS of the lower extremity.
Read other coverage about pain management:
– Branding Pain Management: Q&A With Vishal Lal of Advanced Pain Management
– 5 Points on Adding EMR to a Pain Practice
– 18 Statistics About Pain Management in Surgery Centers
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
